Now Playing
Opinion|Videos|August 1, 2024
Emerging Agents in IPF Treatment
Author(s)Steven D. Nathan, MD
Steven Nathan, MD, discusses breakthrough treatments for idiopathic pulmonary fibrosis.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- There are several agents with new mechanisms of action in the pipeline for idiopathic pulmonary fibrosis (IPF). Which are you most excited about? What is the potential impact these agents, if approved, could have on the IPF treatment landscape?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Advertisement
